Last Updated : October 31, 2024
Details
Program Updates
1. Updates to the Pharmacoeconomic Submission Process and Submission Requirements
Making Our Economic Model Change Logs More Transparent to Our Partners
Transparency is essential in economic modelling to make complex analyses more understandable, reliable, and actionable. We are taking a new step to increase the transparency around how we handle economic models that are submitted by a drug sponsor as part of a drug reimbursement review.
Details
| Call for patient/clinician input open | 30-Oct-24 |
|---|---|
| Call for patient/clinician input closed | 20-Dec-24 |
| Submission received | 11-Dec-24 |
| Submission accepted | 02-Jan-25 |
| Review initiated | 03-Jan-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 09-Apr-25 |
| Deadline for sponsors comments | 22-Apr-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 15-May-25 |
| Expert committee meeting (initial) | 28-May-25 |
| Draft recommendation issued to sponsor | - |
| Clarification: - CDEC recommendation held pending receipt of NOC and evaluation of the finalized submission requirements. . | |
| Draft recommendation posted for stakeholder feedback | - |
| End of feedback period | - |
Last Updated : June 11, 2025
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 28-Nov-2024 |
| Feedback Deadline: | 5-Dec-2024 |
| Final Report Posted : | 21-Jan-2025 |
Last Updated : January 21, 2025
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 05-Dec-2024 |
| Feedback Deadline: | 12-Dec-2024 |
| Final Report Posted: | 22-Jan-2025 |
Last Updated : January 22, 2025
Details
| Call for patient/clinician input open | 24-Oct-24 |
|---|---|
| Call for patient/clinician input closed | 20-Dec-24 |
| Submission received | 05-Dec-24 |
| Submission accepted | 19-Dec-24 |
| Review initiated | 20-Dec-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 24-Mar-25 |
| Deadline for sponsors comments | 02-Apr-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 15-May-25 |
| Expert committee meeting (initial) | 28-May-25 |
| Draft recommendation issued to sponsor | 10-Jun-25 |
| Draft recommendation posted for stakeholder feedback | 19-Jun-25 |
| End of feedback period | 04-Jul-25 |
| Clarification: - Reconsideration: major revisions requested by sponsor - Target CDEC reconsideration meeting date to be determined . | |
Last Updated : July 16, 2025
Details
| Call for patient/clinician input open | October 23, 2024 |
|---|---|
| Call for patient/clinician input closed | December 13, 2024 |
| Submission received | November 29, 2024 |
| Submission accepted | December 13, 2024 |
| Review initiated | December 16, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | April 09, 2025 |
| Deadline for sponsors comments | April 22, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | May 15, 2025 |
| Expert committee meeting (initial) | May 28, 2025 |
| Draft recommendation issued to sponsor | June 09, 2025 |
| Draft recommendation posted for stakeholder feedback | June 19, 2025 |
| End of feedback period | July 04, 2025 |
| Final recommendation issued to sponsor and drug plans | July 21, 2025 |
| Final recommendation posted | August 07, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | August 05, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : August 7, 2025
Details
| Call for patient/clinician input open | 06-Sep-24 |
|---|---|
| Call for patient/clinician input closed | 04-Nov-24 |
| Submission received | 18-Oct-24 |
| Submission accepted | 01-Nov-24 |
| Review initiated | 04-Nov-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 06-Feb-25 |
| Deadline for sponsors comments | 18-Feb-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 13-Mar-25 |
| Expert committee meeting (initial) | 26-Mar-25 |
| Draft recommendation issued to sponsor | - |
| Clarification: - CDEC recommendation held pending receipt of NOC and evaluation of the finalized submission requirements. | |
| Draft recommendation posted for stakeholder feedback | - |
| End of feedback period | - |
Last Updated : April 14, 2025